| 10/12/2010 |
Resignation of Director |
| 08/12/2010 |
Cellmid Launches New Hair Loss Products |
| 16/11/2010 |
Appendix 3B |
| 15/11/2010 |
App 3Y Change in Director’s Interest Notice |
| 10/11/2010 |
Midkine Conference Results |
| 03/11/2010 |
AGM Presentation |
| 03/11/2010 |
Cellmid Launches Midkine Blood Test |
| 03/11/2010 |
Results of the Annual General Meeting of Members |
| 27/10/2010 |
Cellmid Launches Lifesyle Subsidiary |
| 01/10/2010 |
Annual Report to Shareholders |
| 01/10/2010 |
Notice of Annual General Meeting / Proxy Form |
| 15/09/2010 |
Cellmid Secures US$8M Funding |
| 19/08/2010 |
Preclinical Study Shows Reduction in Disease Severity |
| 30/07/2010 |
Appendix 3B |
| 28/07/2010 |
Appendix 4C |
| 09/07/2010 |
Appendix 3B |
| 21/04/2010 |
Appendix 4C |
| 21/04/2010 |
Joint Research Agreement Signed with Kumamoto University |
| 12/04/2010 |
New Midkine Results for Heart Attack Treatment |
| 19/03/2010 |
Validated Cancer Marker Presentation |
| 03/03/2010 |
CDY Signs Collaboration for Heart Attack Treatment |
| 25/02/2010 |
Appendix 4D and Half Year Accounts |
| 25/02/2010 |
Cellmid News |
| 19/02/2010 |
Appendix 3B |
| 29/01/2010 |
Appendix 4C Quarterly Report |
| 18/01/2010 |
Appendix 3B New Issue |
